LGND Ligand Pharmaceuticals
- 72.520
- -6.350-8.05%
- 71.570
- -0.950-1.31%
Ligand Pharmaceuticals News
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Analysis
Price Target
No Data
